Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on August 4, 2025
EverQuote Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 4, 2025
Second Quarter Revenue Growth of 34% Year-Over-Year to $156.6 million Second Quarter Variable Marketing Dollars Increase 25% Year-Over-Year to $45.5 million Delivers Second Quarter Record Net Income of $14.7 million and Adjusted EBITDA of $22.0 million …
Crane NXT to Participate in the Oppenheimer 28th Annual Technology, Internet & Communications Conference
GlobeNewswire
·
August 4, 2025
WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial …
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
GlobeNewswire
·
August 4, 2025
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to manage …
Healthcare Workforce Management Market Surges Amid Drive for Operational Efficiency and Cost Reduction
GlobeNewswire
·
August 4, 2025
Boston, Aug. 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Healthcare Workforce Management System Market” is expected to grow from $1.9 billion in 2024 to $3.1 billion by the end of 2029, at a compound annual …
Yoshida Back Bay Boston Grand Opening Marks a New Era for High-End Japanese Dining in the City
EIN Presswire
·
August 4, 2025
BOSTON, MA, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- In the heart of Boston’s iconic Back Bay, a new culinary gem has arrived. Yoshida Back Bay Boston, located at 51 Massachusetts Avenue, opened its doors this week with the ambition of …
Ransomware in the Crosshairs: Sophos and Halcyon Announce New Intelligence-Sharing and Mutual Anti-Tamper Protection Initiative
GlobeNewswire
·
August 4, 2025
LAS VEGAS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today announced a strategic threat intelligence sharing partnership with Halcyon, the leading anti-ransomware solution …
Stop & Shop Launches “Good Things Are in Store” Brand Campaign to Reinforce Value and Rebuild Customer Trust
GlobeNewswire
·
August 4, 2025
QUINCY, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Stop …
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
GlobeNewswire
·
August 4, 2025
CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Dallan Murray as Chief Commercial Officer, effective …
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
GlobeNewswire
·
August 4, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 4, 2025
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency from baseline, with 22% at 100% seizure reduction in last 28 days Initiated two registrational studies for …
Martha’s Vineyard Sharks Sweep Bristol Blues in Shutout Fashion, Advance to NECBL Southern Division Finals
EIN Presswire
·
August 4, 2025
OAK BLUFFS, MA, UNITED STATES, August 3, 2025 /EINPresswire.com/ -- The Martha’s Vineyard Sharks completed a dominant sweep of the Bristol Blues in the New England Collegiate Baseball League (NECBL) Southern Division Semifinals, clinching the series with …
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
GlobeNewswire
·
August 4, 2025
Mural continues to explore strategic alternatives Estimates cash and cash equivalents of approximately $43 to $48 million at December 31, 2025, if it has not consummated a transaction or other strategic alternative by year end WALTHAM, Mass. and DUBLIN, …
Cerence AI Files Complaint with the International Trade Commission against Sony and TCL
GlobeNewswire
·
August 4, 2025
BURLINGTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that it has filed a complaint with the United States International Trade …
Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine
GlobeNewswire
·
August 4, 2025
Dosing with vormatrigine over 8 weeks led to 56.3% median reduction in seizure frequency Approximately 22% of patients reached 100% reduction in seizure frequency in the last 28 days on treatment Rapid and sustained response, with over 54% of patients …
Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization
GlobeNewswire
·
August 4, 2025
CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the initiation of a post-marketing study …
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)
GlobeNewswire
·
August 4, 2025
- Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 - WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq …
Atavistik Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ATV-1601 in Patients with AKT1 E17K-mutant Solid Tumors
GlobeNewswire
·
August 4, 2025
ATV-1601 is a first-in-class allosteric selective inhibitor of AKT1 E17K Pan-AKT inhibitors offer limited efficacy for patients with AKT1 E17K-driven mutant tumors due to insufficient inhibition of the AKT1 E17K mutation and AKT2-driven tolerability issues …
Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025
GlobeNewswire
·
August 4, 2025
WATERTOWN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report second quarter …
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
GlobeNewswire
·
August 4, 2025
BOSTON, Mass., and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) announced today they have entered into a definitive merger …